Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AUBAGIO for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 20 adverse event reports in the FDA FAERS database where AUBAGIO was used for Relapsing-remitting multiple sclerosis.

Most Reported Side Effects for AUBAGIO

Side Effect Reports % Deaths Hosp.
Alopecia 259 24.0% 1 27
Diarrhoea 172 16.0% 2 25
Nausea 127 11.8% 0 26
Fatigue 97 9.0% 3 25
Drug dose omission 93 8.6% 2 32
Paraesthesia 86 8.0% 1 18
Hypoaesthesia 80 7.4% 2 17
Headache 79 7.3% 1 20
Multiple sclerosis relapse 76 7.1% 3 31
Pain 52 4.8% 0 14
Dizziness 48 4.5% 1 11
Rash 48 4.5% 0 6
Fall 47 4.4% 2 26
Gait disturbance 46 4.3% 1 15
Asthenia 41 3.8% 2 20

Other Indications for AUBAGIO

Multiple sclerosis (869) Product used for unknown indication (94) Multiple sclerosis relapse (6)

Other Drugs Used for Relapsing-remitting multiple sclerosis

OCRELIZUMAB (15,658) FINGOLIMOD (8,814) OFATUMUMAB (3,864) DIMETHYL (3,638) NATALIZUMAB (2,749) INTERFERON BETA-1A (2,058) GLATIRAMER (1,965) ALEMTUZUMAB (1,604) TERIFLUNOMIDE (1,320) RITUXIMAB (956)

Related Pages

AUBAGIO Full Profile All Relapsing-remitting multiple sclerosis Drugs AUBAGIO Demographics AUBAGIO Timeline